Evidence map›Paper›PMID 38903734›Full record

ArticleArXiv2024

Using YOLO v7 to Detect Kidney in Magnetic Resonance Imaging.

Pouria Yazdian Anari, Fiona Obiezu, Nathan Lay, Fatemeh Dehghani Firouzabadi, Aditi Chaurasia, Mahshid Golagha, Shiva Singh, Fatemeh Homayounieh, Aryan Zahergivar, Stephanie Harmon and 9 more

Abstract readPreprint
In one paragraph

Article in ArXiv, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Pouria Yazdian AnariRadiology and Imaging Sciences, Clinical Center, National Institutes of Health, USA.
Fiona ObiezuRadiology and Imaging Sciences, Clinical Center, National Institutes of Health, USA.
Nathan LayArtificial Intelligence Resource, National Institutes of Health, USA.
Fatemeh Dehghani FirouzabadiRadiology and Imaging Sciences, Clinical Center, National Institutes of Health, USA.
Aditi ChaurasiaUrology Oncology Branch, National cancer institutes, National Institutes of Health, USA.
Mahshid GolaghaRadiology and Imaging Sciences, Clinical Center, National Institutes of Health, USA.
Shiva SinghRadiology and Imaging Sciences, Clinical Center, National Institutes of Health, USA.
Fatemeh HomayouniehRadiology and Imaging Sciences, Clinical Center, National Institutes of Health, USA.
Aryan ZahergivarRadiology and Imaging Sciences, Clinical Center, National Institutes of Health, USA.
Stephanie HarmonArtificial Intelligence Resource, National Institutes of Health, USA.
Evrim TurkbeyRadiology and Imaging Sciences, Clinical Center, National Institutes of Health, USA.
Rabindra GautamUrology Oncology Branch, National cancer institutes, National Institutes of Health, USA.
Kevin MaArtificial Intelligence Resource, National Institutes of Health, USA.
Maria MerinoPathology Department, National Cancer Institutes, National Institutes of Health, USA.
Elizabeth C JonesRadiology and Imaging Sciences, Clinical Center, National Institutes of Health, USA.
Mark W BallUrology Oncology Branch, National cancer institutes, National Institutes of Health, USA.
W Marston LinehanUrology Oncology Branch, National cancer institutes, National Institutes of Health, USA.
Baris TurkbeyArtificial Intelligence Resource, National Institutes of Health, USA.
Ashkan A MalayeriRadiology and Imaging Sciences, Clinical Center, National Institutes of Health, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: This study explores the use of the latest You Only Look Once (YOLO V7) object detection method to enhance kidney detection in medical imaging by training and testing a modified YOLO V7 on medical image formats. Methods: Study includes 878 patients with various subtypes of renal cell carcinoma (RCC) and 206 patients with normal kidneys. A total of 5657 MRI scans for 1084 patients were retrieved. 326 patients with 1034 tumors recruited from a retrospective maintained database, and bounding boxes were drawn around their tumors. A primary model was trained on 80% of annotated cases, with 20% saved for testing (primary test set). The best primary model was then used to identify tumors in the remaining 861 patients and bounding box coordinates were generated on their scans using the model. Ten benchmark training sets were created with generated coordinates on not-segmented patients. The final model used to predict the kidney in the primary test set. We reported the positive predictive value (PPV), sensitivity, and mean average precision (mAP). Results: The primary training set showed an average PPV of 0.94 ± 0.01, sensitivity of 0.87 ± 0.04, and mAP of 0.91 ± 0.02. The best primary model yielded a PPV of 0.97, sensitivity of 0.92, and mAP of 0.95. The final model demonstrated an average PPV of 0.95 ± 0.03, sensitivity of 0.98 ± 0.004, and mAP of 0.95 ± 0.01. Conclusion: Using a semi-supervised approach with a medical image library, we developed a high-performing model for kidney detection. Further external validation is required to assess the model's generalizability.

Indexed as

KidneyRenal cell carcinomaYOLO v7

Identifiers

PMID38903734
PMCPMC11188135

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.